WHAT DO WE EXPECT TO VISUALIZE IN RADIOGRAPHS OF MRONJ PATIENTS?

Bisphosphonate-associated osteonecrosis of the jaws (MRONJ/BP-ONJ/ BRONJ) is a commonly seen disease. The main concern is to detect the exposed bone or even before occurring the exposed bone since it is not always painful, therefore a thorough clinical examination and radiological imaging are essential when MRONJ is suspected. In this review the imaging modalieties in regard to MRONJ: X-ray/Panoramic Radiograph, Cone Beam Computed Tomography (CBCT) and Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Imaging will be reviewed.

Keywords:

bisphosphonate , ct,

PDF

___

References 1. Limones, A., et al., Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal, 2020. 25(3): p. e326-e336. 2. Morishita, K., et al., Treatment outcomes of adjunctive teriparatide therapy for medication-related osteonecrosis of the jaw (MRONJ): A multicenter retrospective analysis in Japan. J Orthop Sci, 2020. 3. Dunphy, L., et al., Medication-related osteonecrosis (MRONJ) of the mandible and maxilla. BMJ Case Rep, 2020. 13(1). 4. Kim, M.S., et al., Immediate reconstruction of mandibular defect after treatment of medication-related osteonecrosis of the jaw (MRONJ) with rhBMP-2/ACS and miniplate: Review of 3 cases. Int J Surg Case Rep, 2020. 66: p. 25-29. 5. Ruggiero, S.L., et al., American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg, 2014. 72(10): p. 1938-56. 6. Berg, B.I., et al., Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ). Dent J (Basel), 2016. 4(3). 7. Brierly, G.I., et al., Investigation of Sustained BMP Delivery in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ) in a Rat Model. Macromol Biosci, 2019. 19(11): p. e1900226. 8. Ristow, O., et al., Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ). J Craniomaxillofac Surg, 2015. 43(2): p. 290-3. 9. Wadia, R., Peri-implant MRONJ. Br Dent J, 2020. 228(6): p. 422. 10. Jasper, V., et al., Medication-related osteonecrosis of the jaw (MRONJ) stage III: Conservative and conservative surgical approaches versus an aggressive surgical intervention: A systematic review. J Craniomaxillofac Surg, 2020. 48(4): p. 435-443. 11. Steel, B.J., Management of Medication-related Osteonecrosis of the Jaw (MRONJ) risk in patients due to commence anti-resorptive/anti-angiogenic drugs - how should pre-drug-treatment dental preventive care be organised? Community Dent Health, 2019. 36(4): p. 244-254. 12. Rao, N.J., et al., Effect of Periapical Diseases in Development of MRONJ in Immunocompromised Mouse Model. Biomed Res Int, 2019. 2019: p. 1271492. 13. Sarmiento, L.A., Resolution without surgery of an advanced stage of medication-related osteonecrosis of the jaw (MRONJ) in a patient who could not suspend her treatment for osteoporosis. Oral Oncol, 2019. 99: p. 104318. 14. Zirk, M., et al., Volumetric analysis of MRONJ lesions by semiautomatic segmentation of CBCT images. Oral Maxillofac Surg, 2019. 23(4): p. 465-472. 15. Shibahara, T., Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan. Jpn Dent Sci Rev, 2019. 55(1): p. 71-75. 16. Wazzan, T., et al., Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study. Spec Care Dentist, 2018. 38(6): p. 356-361. 17. Subramanian, G., et al., Identifying MRONJ-affected bone with digital fusion of functional imaging (FI) and cone-beam computed tomography (CBCT): case reports and hypothesis. Oral Surg Oral Med Oral Pathol Oral Radiol, 2017. 123(3): p. e106-e116. 18. Stockmann, P., et al., Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study. Clin Oral Investig, 2010. 14(3): p. 311-7. 19. Unsal, G., et al., Medication-Related Osteonecrosis of the Jaw – A Case Report. ACTA SCIENTIFIC DENTAL SCIENCES, 2017. 1(5). 20. Goller-Bulut, D., G. Ozcan, and F. Avci, Changes in dimension of neurovascular canals in the mandible and maxilla: A radiographic finding in patients diagnosed with MRONJ. Med Oral Patol Oral Cir Bucal, 2018. 23(3): p. e282-e289. 21. Miyashita, H., et al., Three-dimensional radiologic-pathologic correlation of medication-related osteonecrosis of the jaw using 3D bone SPECT/CT imaging. Dentomaxillofac Radiol, 2019. 48(8): p. 20190208. 22. Miyashita, H., et al., Clinical value of 3D SPECT/CT imaging for assessing jaw bone invasion in oral cancer patients. J Craniomaxillofac Surg, 2019. 47(7): p. 1139-1146. 23. Miyashita, H., et al., Clinical utility of three-dimensional SPECT/CT imaging as a guide for the resection of medication-related osteonecrosis of the jaw. Int J Oral Maxillofac Surg, 2015. 44(9): p. 1106-9. 24. Fleisher, K.E., et al., Does Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography Facilitate Treatment of Medication-Related Osteonecrosis of the Jaw? J Oral Maxillofac Surg, 2016. 74(5): p. 945-58. 25. Koenig, L.J., Diagnostic Imaging Oral and Maxillofacial. Vol. 1. 2011: Amirsys, Inc. 26. White, S.C. and M.J. Pharoah, Oral Radiology : Principles and Interpretation. 7th ed. 2014: Elsevier Inc. 679.